S100A7 and arthritic joint disease: Similarly, S100A7 polymorphisms regulating gene expression might affect RA susceptibility, severity, and risk of early onset of arthritis, potentially as well as the therapeutic response to either glucocorticoid or adrenocorticotrophic hormone.